about
From Alport syndrome to benign familial hematuria: clinical and genetic aspectRenal vein infarction, a complication of paroxysmal nocturnal hemoglobinuriaTSC2, a key player in tumor suppression and cystic kidney disease[Prospective: How will renal, prostatic and urothelial tumours be treated in 10 years?][Glomerulonephritis with IgA mesangial deposits].[T2HD Study. Oral anticoagulants and antiplatelet agents: Practices, benefits, and risks in the chronic hemodialysis population. Observational data].[Occupational exposure to blood and body fluids in haemodialysis health care workers: epidemiological data and prevention in France].[Nephrotoxicity of sirolimus: experimental and clinical data].[Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].[RDPLF and Rein, 2 complementary registries: a comparison of the collected data].[Nephrogenic diabetes insipidus].[New complete blood count parameter to evaluate iron status of haemodialysis patients].[Mycophenolate mofetil restores renal function and spares steroids during idiopathic nephrotic syndrome in children. A cohort study].[Hereditary hemolytic uremic syndromes and thrombotic thrombocytopenic purpura].[Hemolytic and uremic syndrome in the child].[Hemolytic uremic syndrome in adults].[Use of fondaparinux during hemodialysis in heparin-induced thrombocytopenia. About a new observation].[Acute renal failure as a complication of Mediterranean spotted fever].[Cytopenias following kidney transplantation].[Acute pancreatitis and thrombotic microangiopathy: a two-way association].[Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?].[Acute pyelonephritis and thrombocytopenia].[Antiphospholipid syndrome in nephrology. Kidney damage and practical aspects of the management].[Spectrum of renal manifestations in sickle cell disease].[TTP or HUS? About a case revealing an IgA nephropathy].[Atypic hemolytic uremic syndrome taken for Goodpasture's syndrome: A case report].[Results of conservative management of emphysematous pyelonephritis].[Colic angiodysplasia and chronic haemodialysis. Argon plasma treatment. A case report].[Dialysis dose, nutrition, inflammation: what is the relationship? Data from the Dialysis Outcomes and Practices Patterns Study (DOPPS)].[Quinine-induced renal bilateral cortical necrosis].[Renal biopsy practice: results of a French study and recommendations].Socio-economic impact in CKD.[Proliferative lupus nephritis treatment: practice survey in nephrology and internal medicine in France].[Autosomal dominant polycystic kidney disease: is the treatment for tomorrow?].[ERBP guideline on the management and evaluation of the kidney donor and recipient].[Beware, polyarteritis nodosa still exists in nephrology!]The influence of mortality rate from membrane flux for end-stage renal disease: A meta-analysis.New insights on inflammation in chronic kidney disease-genetic and non-genetic factors.[Microbial nucleic acids in the pathogenesis of glomerulonephritis].The contribution of adult stem cells to renal repair.
P1433
Q28256548-83DD0C11-C971-460F-B5D0-7031EB8C0183Q28266966-E23EA39C-CDF6-4930-B81E-5AFC27D8E670Q28293831-5ADF2A7A-2721-415E-92F0-FEE62C6A6436Q30234107-B6D9F3B8-F77F-496C-AE01-D0990079907BQ30981216-A105E41D-1591-49A8-8C86-3740C62FEFA8Q31029975-9345C4ED-A2E8-4EE6-9357-5B75230B5678Q31052422-CD022CB9-5299-409B-AFD6-FB5730F82984Q31060382-420D17D2-937E-4DBC-88EF-8F2E8FCE89CCQ31106117-F5CC5637-0DEA-425E-A4AC-0BAC41BFAA63Q31106781-13C45FED-5F1A-4661-8A35-6491CBA137CEQ33262576-E4708464-B081-4FB7-8239-1943FEB5DD5BQ33279423-0C3F86ED-F24E-48A8-B54D-FA454DFE0472Q33311655-DE5073DF-C539-4497-87BB-2613CB7D7D03Q33374633-5F7167F8-9F48-4027-A9D9-2C991D4E13E7Q33377169-367B7454-0905-4393-9FF9-73BAFF829897Q33389181-4441FC18-B374-45E2-AE0E-00E0BBD9C931Q33391006-E34C0A9B-C561-45FC-ADE7-05A217E4AF67Q33394641-F1C54BA6-4422-4199-A90F-8966DCCB33BCQ33395405-2A789269-ECA7-4DDC-930C-22ED1AA89D4EQ33395938-3F33379C-2B17-40C5-9A92-0401F19BE3B5Q33404979-BE3CFDB9-654E-4A74-B64A-9DE2CBA96774Q33408542-18DB00A7-80FA-4FF5-BDE4-0F050FE81B61Q33410832-B64C26BE-5DA0-4459-A5CF-AA7F7B4690B8Q33410834-1FE9672B-F0E6-4F60-9CD7-E248560B757BQ33419066-815F1D7D-A65C-4C80-B76A-598067B71A42Q33426808-0B5C4FA9-27A3-47A3-A758-56DA70816A74Q33436342-7A08E1BB-0105-4FA8-A107-6ACEFDA1F5C8Q33562568-EA626694-A5C6-4D7B-8B5E-65324C0552C9Q33668256-3647086F-1169-4D7E-9D0F-75A3B5ED3989Q33845543-86D6678E-7421-4A7F-AF47-BEC54611EC01Q34198699-DB83189E-408F-43E5-8B03-8EC2C5FF2D4AQ34547714-C4934A47-3223-4E7B-A928-12F6967982C6Q35139798-DD06AAC3-7893-4313-A112-E5F47A25A1B8Q35217764-CFA5F554-58E6-47B3-971E-03C30E6BE24DQ35328501-4E779EC9-12A5-400A-AA55-E33493A2CB22Q36148764-A365E3C3-34FB-493B-9990-87E55EE58B41Q36190791-A1D1F9FE-84E2-442C-8DE2-77DD0B3067E3Q36556972-2FA4F96A-61BA-4193-A162-13FEF0F565E8Q36690759-E090CD8F-2D86-46C5-858D-DA8FB27D5D71Q36769490-CF2C793F-C01A-4314-ADE1-A09C160A9631
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Nephrologie & therapeutique
@ast
Nephrologie & therapeutique
@en
Nephrologie & therapeutique
@es
Nephrologie & therapeutique
@nl
type
label
Nephrologie & therapeutique
@ast
Nephrologie & therapeutique
@en
Nephrologie & therapeutique
@es
Nephrologie & therapeutique
@nl
altLabel
Nephrol Ther
@en
Nephrol. Ther.
@en
prefLabel
Nephrologie & therapeutique
@ast
Nephrologie & therapeutique
@en
Nephrologie & therapeutique
@es
Nephrologie & therapeutique
@nl
P31
P3181
P1055
P1156
P123
P1277
P1476
Nephrologie & therapeutique
@en